img

Global Canine Influenza Vaccine Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Canine Influenza Vaccine Market Insights, Forecast to 2034

Canine influenza is influenza occurring in canine animals. Canine influenza is caused by varieties of influenzavirus A, such as equine influenza virus H3N8, which was discovered to cause disease in canines in 2004. Because of the lack of previous exposure to this virus, dogs have no natural immunity to it. Therefore, the disease is rapidly transmitted between individual dogs. Canine influenza may be endemic in some regional dog populations of the United States. It is a disease with a high morbidity but a low incidence of death.
Global Canine Influenza Vaccine market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Canine Influenza Vaccine industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Canine Influenza Vaccine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Canine Influenza Vaccine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bharat Biotech
GSK
Novartis
Merck Animal Health
Roche
Zoetis
CSL Limited
CNBG
LIAONING CHENGDA
Segment by Type
H3N2 Vaccine
H3N8 Vaccine

Segment by Application


Vaccination Clinic
Pet Hospital
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Canine Influenza Vaccine plant distribution, commercial date of Canine Influenza Vaccine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Canine Influenza Vaccine introduction, etc. Canine Influenza Vaccine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Canine Influenza Vaccine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Canine Influenza Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Canine Influenza Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 H3N2 Vaccine
1.2.3 H3N8 Vaccine
1.3 Market by Application
1.3.1 Global Canine Influenza Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Vaccination Clinic
1.3.3 Pet Hospital
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Canine Influenza Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Canine Influenza Vaccine Revenue by Region
2.2.1 Global Canine Influenza Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Canine Influenza Vaccine Revenue by Region (2018-2024)
2.2.3 Global Canine Influenza Vaccine Revenue by Region (2024-2029)
2.2.4 Global Canine Influenza Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Canine Influenza Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Canine Influenza Vaccine Sales by Region
2.4.1 Global Canine Influenza Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Canine Influenza Vaccine Sales by Region (2018-2024)
2.4.3 Global Canine Influenza Vaccine Sales by Region (2024-2029)
2.4.4 Global Canine Influenza Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Canine Influenza Vaccine Sales by Manufacturers
3.1.1 Global Canine Influenza Vaccine Sales by Manufacturers (2018-2024)
3.1.2 Global Canine Influenza Vaccine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Canine Influenza Vaccine in 2022
3.2 Global Canine Influenza Vaccine Revenue by Manufacturers
3.2.1 Global Canine Influenza Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Canine Influenza Vaccine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Canine Influenza Vaccine Revenue in 2022
3.3 Global Key Players of Canine Influenza Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Canine Influenza Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Canine Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Canine Influenza Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Canine Influenza Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Canine Influenza Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Canine Influenza Vaccine Sales by Type
4.1.1 Global Canine Influenza Vaccine Historical Sales by Type (2018-2024)
4.1.2 Global Canine Influenza Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Canine Influenza Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Canine Influenza Vaccine Revenue by Type
4.2.1 Global Canine Influenza Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Canine Influenza Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Canine Influenza Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Canine Influenza Vaccine Price by Type
4.3.1 Global Canine Influenza Vaccine Price by Type (2018-2024)
4.3.2 Global Canine Influenza Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Canine Influenza Vaccine Sales by Application
5.1.1 Global Canine Influenza Vaccine Historical Sales by Application (2018-2024)
5.1.2 Global Canine Influenza Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Canine Influenza Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Canine Influenza Vaccine Revenue by Application
5.2.1 Global Canine Influenza Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Canine Influenza Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Canine Influenza Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Canine Influenza Vaccine Price by Application
5.3.1 Global Canine Influenza Vaccine Price by Application (2018-2024)
5.3.2 Global Canine Influenza Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Canine Influenza Vaccine Market Size by Type
6.1.1 US & Canada Canine Influenza Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Canine Influenza Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Canine Influenza Vaccine Market Size by Application
6.2.1 US & Canada Canine Influenza Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Canine Influenza Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Canine Influenza Vaccine Market Size by Country
6.3.1 US & Canada Canine Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Canine Influenza Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Canine Influenza Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Canine Influenza Vaccine Market Size by Type
7.1.1 Europe Canine Influenza Vaccine Sales by Type (2018-2029)
7.1.2 Europe Canine Influenza Vaccine Revenue by Type (2018-2029)
7.2 Europe Canine Influenza Vaccine Market Size by Application
7.2.1 Europe Canine Influenza Vaccine Sales by Application (2018-2029)
7.2.2 Europe Canine Influenza Vaccine Revenue by Application (2018-2029)
7.3 Europe Canine Influenza Vaccine Market Size by Country
7.3.1 Europe Canine Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Canine Influenza Vaccine Sales by Country (2018-2029)
7.3.3 Europe Canine Influenza Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Canine Influenza Vaccine Market Size
8.1.1 China Canine Influenza Vaccine Sales (2018-2029)
8.1.2 China Canine Influenza Vaccine Revenue (2018-2029)
8.2 China Canine Influenza Vaccine Market Size by Application
8.2.1 China Canine Influenza Vaccine Sales by Application (2018-2029)
8.2.2 China Canine Influenza Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Canine Influenza Vaccine Market Size by Type
9.1.1 Asia Canine Influenza Vaccine Sales by Type (2018-2029)
9.1.2 Asia Canine Influenza Vaccine Revenue by Type (2018-2029)
9.2 Asia Canine Influenza Vaccine Market Size by Application
9.2.1 Asia Canine Influenza Vaccine Sales by Application (2018-2029)
9.2.2 Asia Canine Influenza Vaccine Revenue by Application (2018-2029)
9.3 Asia Canine Influenza Vaccine Sales by Region
9.3.1 Asia Canine Influenza Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Canine Influenza Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Canine Influenza Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Canine Influenza Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Canine Influenza Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Canine Influenza Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Canine Influenza Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Canine Influenza Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Canine Influenza Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Canine Influenza Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Canine Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Canine Influenza Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Canine Influenza Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Bharat Biotech
11.1.1 Bharat Biotech Company Information
11.1.2 Bharat Biotech Overview
11.1.3 Bharat Biotech Canine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Bharat Biotech Canine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bharat Biotech Recent Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Overview
11.2.3 GSK Canine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 GSK Canine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Overview
11.3.3 Novartis Canine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Novartis Canine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 Merck Animal Health
11.4.1 Merck Animal Health Company Information
11.4.2 Merck Animal Health Overview
11.4.3 Merck Animal Health Canine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Merck Animal Health Canine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck Animal Health Recent Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Overview
11.5.3 Roche Canine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Roche Canine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Roche Recent Developments
11.6 Zoetis
11.6.1 Zoetis Company Information
11.6.2 Zoetis Overview
11.6.3 Zoetis Canine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Zoetis Canine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Zoetis Recent Developments
11.7 CSL Limited
11.7.1 CSL Limited Company Information
11.7.2 CSL Limited Overview
11.7.3 CSL Limited Canine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 CSL Limited Canine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 CSL Limited Recent Developments
11.8 CNBG
11.8.1 CNBG Company Information
11.8.2 CNBG Overview
11.8.3 CNBG Canine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 CNBG Canine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 CNBG Recent Developments
11.9 LIAONING CHENGDA
11.9.1 LIAONING CHENGDA Company Information
11.9.2 LIAONING CHENGDA Overview
11.9.3 LIAONING CHENGDA Canine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 LIAONING CHENGDA Canine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 LIAONING CHENGDA Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Canine Influenza Vaccine Industry Chain Analysis
12.2 Canine Influenza Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Canine Influenza Vaccine Production Mode & Process
12.4 Canine Influenza Vaccine Sales and Marketing
12.4.1 Canine Influenza Vaccine Sales Channels
12.4.2 Canine Influenza Vaccine Distributors
12.5 Canine Influenza Vaccine Customers
13 Market Dynamics
13.1 Canine Influenza Vaccine Industry Trends
13.2 Canine Influenza Vaccine Market Drivers
13.3 Canine Influenza Vaccine Market Challenges
13.4 Canine Influenza Vaccine Market Restraints
14 Key Findings in The Global Canine Influenza Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Canine Influenza Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of H3N2 Vaccine
Table 3. Major Manufacturers of H3N8 Vaccine
Table 4. Global Canine Influenza Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Canine Influenza Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Canine Influenza Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Canine Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Canine Influenza Vaccine Revenue Market Share by Region (2018-2024)
Table 9. Global Canine Influenza Vaccine Revenue Market Share by Region (2024-2029)
Table 10. Global Canine Influenza Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Canine Influenza Vaccine Sales by Region (2018-2024) & (K Doses)
Table 12. Global Canine Influenza Vaccine Sales by Region (2024-2029) & (K Doses)
Table 13. Global Canine Influenza Vaccine Sales Market Share by Region (2018-2024)
Table 14. Global Canine Influenza Vaccine Sales Market Share by Region (2024-2029)
Table 15. Global Canine Influenza Vaccine Sales by Manufacturers (2018-2024) & (K Doses)
Table 16. Global Canine Influenza Vaccine Sales Share by Manufacturers (2018-2024)
Table 17. Global Canine Influenza Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Canine Influenza Vaccine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Canine Influenza Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Canine Influenza Vaccine Price by Manufacturers 2018-2024 (USD/Dose)
Table 21. Global Canine Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Canine Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Influenza Vaccine as of 2022)
Table 23. Global Key Manufacturers of Canine Influenza Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Canine Influenza Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Canine Influenza Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Canine Influenza Vaccine Sales by Type (2018-2024) & (K Doses)
Table 28. Global Canine Influenza Vaccine Sales by Type (2024-2029) & (K Doses)
Table 29. Global Canine Influenza Vaccine Sales Share by Type (2018-2024)
Table 30. Global Canine Influenza Vaccine Sales Share by Type (2024-2029)
Table 31. Global Canine Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Canine Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Canine Influenza Vaccine Revenue Share by Type (2018-2024)
Table 34. Global Canine Influenza Vaccine Revenue Share by Type (2024-2029)
Table 35. Canine Influenza Vaccine Price by Type (2018-2024) & (USD/Dose)
Table 36. Global Canine Influenza Vaccine Price Forecast by Type (2024-2029) & (USD/Dose)
Table 37. Global Canine Influenza Vaccine Sales by Application (2018-2024) & (K Doses)
Table 38. Global Canine Influenza Vaccine Sales by Application (2024-2029) & (K Doses)
Table 39. Global Canine Influenza Vaccine Sales Share by Application (2018-2024)
Table 40. Global Canine Influenza Vaccine Sales Share by Application (2024-2029)
Table 41. Global Canine Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Canine Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Canine Influenza Vaccine Revenue Share by Application (2018-2024)
Table 44. Global Canine Influenza Vaccine Revenue Share by Application (2024-2029)
Table 45. Canine Influenza Vaccine Price by Application (2018-2024) & (USD/Dose)
Table 46. Global Canine Influenza Vaccine Price Forecast by Application (2024-2029) & (USD/Dose)
Table 47. US & Canada Canine Influenza Vaccine Sales by Type (2018-2024) & (K Doses)
Table 48. US & Canada Canine Influenza Vaccine Sales by Type (2024-2029) & (K Doses)
Table 49. US & Canada Canine Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Canine Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Canine Influenza Vaccine Sales by Application (2018-2024) & (K Doses)
Table 52. US & Canada Canine Influenza Vaccine Sales by Application (2024-2029) & (K Doses)
Table 53. US & Canada Canine Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Canine Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Canine Influenza Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Canine Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Canine Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Canine Influenza Vaccine Sales by Country (2018-2024) & (K Doses)
Table 59. US & Canada Canine Influenza Vaccine Sales by Country (2024-2029) & (K Doses)
Table 60. Europe Canine Influenza Vaccine Sales by Type (2018-2024) & (K Doses)
Table 61. Europe Canine Influenza Vaccine Sales by Type (2024-2029) & (K Doses)
Table 62. Europe Canine Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Canine Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Canine Influenza Vaccine Sales by Application (2018-2024) & (K Doses)
Table 65. Europe Canine Influenza Vaccine Sales by Application (2024-2029) & (K Doses)
Table 66. Europe Canine Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Canine Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Canine Influenza Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Canine Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Canine Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Canine Influenza Vaccine Sales by Country (2018-2024) & (K Doses)
Table 72. Europe Canine Influenza Vaccine Sales by Country (2024-2029) & (K Doses)
Table 73. China Canine Influenza Vaccine Sales by Type (2018-2024) & (K Doses)
Table 74. China Canine Influenza Vaccine Sales by Type (2024-2029) & (K Doses)
Table 75. China Canine Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Canine Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Canine Influenza Vaccine Sales by Application (2018-2024) & (K Doses)
Table 78. China Canine Influenza Vaccine Sales by Application (2024-2029) & (K Doses)
Table 79. China Canine Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Canine Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Canine Influenza Vaccine Sales by Type (2018-2024) & (K Doses)
Table 82. Asia Canine Influenza Vaccine Sales by Type (2024-2029) & (K Doses)
Table 83. Asia Canine Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Canine Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Canine Influenza Vaccine Sales by Application (2018-2024) & (K Doses)
Table 86. Asia Canine Influenza Vaccine Sales by Application (2024-2029) & (K Doses)
Table 87. Asia Canine Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Canine Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Canine Influenza Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Canine Influenza Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Canine Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Canine Influenza Vaccine Sales by Region (2018-2024) & (K Doses)
Table 93. Asia Canine Influenza Vaccine Sales by Region (2024-2029) & (K Doses)
Table 94. Middle East, Africa and Latin America Canine Influenza Vaccine Sales by Type (2018-2024) & (K Doses)
Table 95. Middle East, Africa and Latin America Canine Influenza Vaccine Sales by Type (2024-2029) & (K Doses)
Table 96. Middle East, Africa and Latin America Canine Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Canine Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Canine Influenza Vaccine Sales by Application (2018-2024) & (K Doses)
Table 99. Middle East, Africa and Latin America Canine Influenza Vaccine Sales by Application (2024-2029) & (K Doses)
Table 100. Middle East, Africa and Latin America Canine Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Canine Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Canine Influenza Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Canine Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Canine Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Canine Influenza Vaccine Sales by Country (2018-2024) & (K Doses)
Table 106. Middle East, Africa and Latin America Canine Influenza Vaccine Sales by Country (2024-2029) & (K Doses)
Table 107. Bharat Biotech Company Information
Table 108. Bharat Biotech Description and Major Businesses
Table 109. Bharat Biotech Canine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2024)
Table 110. Bharat Biotech Canine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Bharat Biotech Recent Developments
Table 112. GSK Company Information
Table 113. GSK Description and Major Businesses
Table 114. GSK Canine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2024)
Table 115. GSK Canine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. GSK Recent Developments
Table 117. Novartis Company Information
Table 118. Novartis Description and Major Businesses
Table 119. Novartis Canine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2024)
Table 120. Novartis Canine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Novartis Recent Developments
Table 122. Merck Animal Health Company Information
Table 123. Merck Animal Health Description and Major Businesses
Table 124. Merck Animal Health Canine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2024)
Table 125. Merck Animal Health Canine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Merck Animal Health Recent Developments
Table 127. Roche Company Information
Table 128. Roche Description and Major Businesses
Table 129. Roche Canine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2024)
Table 130. Roche Canine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Roche Recent Developments
Table 132. Zoetis Company Information
Table 133. Zoetis Description and Major Businesses
Table 134. Zoetis Canine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2024)
Table 135. Zoetis Canine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Zoetis Recent Developments
Table 137. CSL Limited Company Information
Table 138. CSL Limited Description and Major Businesses
Table 139. CSL Limited Canine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2024)
Table 140. CSL Limited Canine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. CSL Limited Recent Developments
Table 142. CNBG Company Information
Table 143. CNBG Description and Major Businesses
Table 144. CNBG Canine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2024)
Table 145. CNBG Canine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. CNBG Recent Developments
Table 147. LIAONING CHENGDA Company Information
Table 148. LIAONING CHENGDA Description and Major Businesses
Table 149. LIAONING CHENGDA Canine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2024)
Table 150. LIAONING CHENGDA Canine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. LIAONING CHENGDA Recent Developments
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Canine Influenza Vaccine Distributors List
Table 155. Canine Influenza Vaccine Customers List
Table 156. Canine Influenza Vaccine Market Trends
Table 157. Canine Influenza Vaccine Market Drivers
Table 158. Canine Influenza Vaccine Market Challenges
Table 159. Canine Influenza Vaccine Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Canine Influenza Vaccine Product Picture
Figure 2. Global Canine Influenza Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Canine Influenza Vaccine Market Share by Type in 2022 & 2029
Figure 4. H3N2 Vaccine Product Picture
Figure 5. H3N8 Vaccine Product Picture
Figure 6. Global Canine Influenza Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Canine Influenza Vaccine Market Share by Application in 2022 & 2029
Figure 8. Vaccination Clinic
Figure 9. Pet Hospital
Figure 10. Others
Figure 11. Canine Influenza Vaccine Report Years Considered
Figure 12. Global Canine Influenza Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Canine Influenza Vaccine Revenue 2018-2029 (US$ Million)
Figure 14. Global Canine Influenza Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Canine Influenza Vaccine Revenue Market Share by Region (2018-2029)
Figure 16. Global Canine Influenza Vaccine Sales 2018-2029 ((K Doses)
Figure 17. Global Canine Influenza Vaccine Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Canine Influenza Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 19. US & Canada Canine Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Canine Influenza Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 21. Europe Canine Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Canine Influenza Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 23. China Canine Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Canine Influenza Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 25. Asia (excluding China) Canine Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Canine Influenza Vaccine Sales YoY (2018-2029) & (K Doses)
Figure 27. Middle East, Africa and Latin America Canine Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Canine Influenza Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Canine Influenza Vaccine in the World: Market Share by Canine Influenza Vaccine Revenue in 2022
Figure 30. Global Canine Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Canine Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 32. Global Canine Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 33. Global Canine Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 34. Global Canine Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Canine Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Canine Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Canine Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Canine Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Canine Influenza Vaccine Revenue Share by Country (2018-2029)
Figure 40. US & Canada Canine Influenza Vaccine Sales Share by Country (2018-2029)
Figure 41. U.S. Canine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Canine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Canine Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 44. Europe Canine Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 45. Europe Canine Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 46. Europe Canine Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 47. Europe Canine Influenza Vaccine Revenue Share by Country (2018-2029)
Figure 48. Europe Canine Influenza Vaccine Sales Share by Country (2018-2029)
Figure 49. Germany Canine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 50. France Canine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Canine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Canine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Canine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 54. China Canine Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 55. China Canine Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 56. China Canine Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 57. China Canine Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 58. Asia Canine Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 59. Asia Canine Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 60. Asia Canine Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 61. Asia Canine Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 62. Asia Canine Influenza Vaccine Revenue Share by Region (2018-2029)
Figure 63. Asia Canine Influenza Vaccine Sales Share by Region (2018-2029)
Figure 64. Japan Canine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Canine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Canine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Canine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. India Canine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Canine Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Canine Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Canine Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Canine Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Canine Influenza Vaccine Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Canine Influenza Vaccine Sales Share by Country (2018-2029)
Figure 75. Brazil Canine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Canine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Canine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Canine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Canine Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 80. Canine Influenza Vaccine Value Chain
Figure 81. Canine Influenza Vaccine Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries